Navigation Links
Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
Date:5/14/2008

- Two 4-week cohorts will evaluate R7128 1000mg BID in HCV genotype 1 treatment-naive patients and R7128 1500mg BID in HCV genotypes 2 or 3

treatment-experienced patients -

PRINCETON, N.J., May 14 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) has commenced dosing two additional cohorts of a 4-week Phase 1 study of R7128 in combination with Pegasys(R) (peginterferon alfa-2a) plus Copegus(R) (ribavirin) in both treatment-naive and treatment-experienced patients chronically-infected with hepatitis C virus (HCV) genotypes 1, 2 and 3. R7128, a prodrug of PSI-6130, is a nucleoside analogue polymerase inhibitor of HCV that is being developed through Pharmasset's collaboration with Roche.

The purpose of this 4-week study is to evaluate the safety, tolerability, pharmacokinetics and antiviral activity of R7128 in the clinically-relevant setting of combination therapy for chronic HCV infection. The previously planned Cohort 3 will continue dose-exploration with administration of R7128 1000mg twice-daily (BID) in treatment-naive patients with HCV genotype 1. Cohort 4 will evaluate R7128 1500mg BID administered in combination with Pegasys plus Copegus in treatment-experienced patients with genotypes 2 or 3 who did not achieve a sustained virologic response (SVR) with previous interferon-based therapy.

There will be 25 patients in each dose cohort with 20 patients randomized to receive R7128 and 5 patients randomized to receive placebo. After completing 4 weeks of the triple combination regimen and a follow-up period of 4 weeks of Pegasys plus Copegus, patients will receive an additional 16 to 40 weeks of open-label dosing of Pegasys plus Copegus under a separate protocol to complete the stand
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
10. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
11. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Nonin Medical, a global leader in ... Operating Officer Steve Bucholz will retire May ... his role as Chief Executive Officer. In addition, Mr. ... Officer. Operations will transition to David Noel , ... has been instrumental to Nonin Medical,s growth," Mr. Isaacson ...
(Date:4/17/2015)... DUBLIN , Apr. 17, 2015 Research and ... addition of the "ADME-Toxicology Testing - Global Strategic ... This report analyzes the worldwide markets for ADME-Toxicology Testing ... (In-Vivo, & In-Vitro), and ADME Testing. The ... Canada , Japan , ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Oxygen Systems - Global Strategic Business Report" ... the worldwide markets for Medical Oxygen Systems in US$ ... Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. ... Canada , Japan ...
Breaking Medicine Technology:Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
... Michael Porter, Ph.D., has joined the board of ... biotechnology company focused on the discovery and development ...   http://photos.prnewswire.com/prnh/20110125/NE34069 ) Professor Porter, ... Business School, is recognized as a leading authority ...
... 2011 CardioFocus announced that two "live cases" ... The first live case was a satellite transmission ... broadcast to the 16th Annual Boston Symposium on ... the treatment of atrial fibrillation served as moderators ...
Cached Medicine Technology:Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors 2Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors 3Two Laser Balloon 'Live Cases' Shed New Light on Direct Visualization and PV Ablation 2
(Date:4/19/2015)... Fla. (PRWEB) April 19, 2015 The ... DO, MPH, MHCM, FACS, as the inaugural winner of ... at its annual meeting, April 18, in Las Vegas, ... Medical Group, vice chairman of the department of surgery ... and Medical Center in Hartford, Connecticut, was instrumental in ...
(Date:4/19/2015)... Carinsurancesavings.biz has released a new blog post explaining how ... have diabetes. , Clients who have diabetes can ... released blog post explains how diabetes influences auto insurance ... cost coverage. , It is now possible to ... website. Clients can visit http://carinsurancesavings.biz for quotes ...
(Date:4/19/2015)... A live auction will be held to sell ... in Brooklyn, NY and other national consignors. Various types of ... exam and much more. , The auction will take ... 9:00am CDT each day. The equipment is at their Chicago ... 60160. Anyone can participate in the auction including those ...
(Date:4/19/2015)... 19, 2015 HealthPostures, LLC , a ... it will exhibit it’s pioneering ergonomics products at the ... Iowa-Illinois Safety Council Professional Development Conference and Expo . ... EZ are used in volume by call centers, educational ... Built to clamp to a desk, the TaskMate Go ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancequotesinfo.com has ... insurance can cover physical injuries caused by a ... excellent financial coverage for a vehicle. A policy can ... by an accident. Drivers should always carry appropriate coverage ... insurance policy can be bought with several important riders ...
Breaking Medicine News(10 mins):Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Finding Low Cost Auto Insurance for Diabetic Drivers! 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2
... Surface Logix Inc. today announced the initiation of a ... secondary Raynaud's disease. SLx-2101 is a novel , long-acting ... associated with vascular dysfunction such as Raynaud's, a vasospastic ... reduction of blood flow to areas such as the ...
... believe that it is easier to get the child admitted to ... ,People depending on private health care find it inadequate. Often they ... their homes. , ,A new survey suggests that many of ... child. This saves thousands of pounds for the family. The research ...
... its first manned mission to Mars, it has taken its first ... you get rid of the body of a dead astronaut on ... be pulled on a critically ill astronaut who is using up ... employ DNA testing to weed out astronauts who might get a ...
... are used to shock the heart back to normal are found ... out of five fails to work after just ten years. On ... default. , The wire or the lead sometimes shocked ... beating abnormally or completely stopped. ,Many a times it ...
... soup before a meal can help cut back on how much ... State study shows . Results show that when participants in the ... they reduced their total calorie intake at lunch by 20 percent, ... ,"This study expands on previous studies about consuming lower-calorie soup as ...
... Indian origin optician who was part of a British charity, made ... in India. ,Premal Patel, who was part of a ... record 850 eye examinations in a day in the Indian city ... sight difficulties in developing countries. ,'The best moment was ...
Cached Medicine News:Health News:Surface Logix Commences Phase 2a Clinical Trial of SLx-2101 in Raynaud's Disease 2Health News:Inadequate Childcare Hits Wales 2Health News:NASA Gets Ready To Address Tough Questions 2Health News:NASA Gets Ready To Address Tough Questions 3Health News:Taking Low-calorie Soup Before Meal Will Help Cut Calories at Meals 2
Take Performance to a Higher Level....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
... used to seal the arterial puncture site. Duett ... the arteriotomy and the tissue tract with a ... a balloon catheter and procoagulant - the Duett ... stop the bleeding. The Duett is unique in ...
Medicine Products: